Applied Materials, Inc. (AMAT) financial statements: income statement, balance sheet and cash flow
Applied Materials, Inc.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Oct 26, 2025 · FY), Applied Materials, Inc. reported revenue of $28.4B (+4.4% year on year) and net income of $7.0B (-2.5% year on year).
Income statement
Applied Materials, Inc. income statement, fiscal years
Line item
Oct 26, 2025 · FY
Oct 27, 2024 · FY
Oct 29, 2023 · FY
Oct 30, 2022 · FY
Net revenue
$28.4B
$27.2B
$26.5B
$25.8B
Cost of products sold
$14.6B
$14.3B
$14.1B
$13.8B
Gross profit
$13.8B
$12.9B
$12.4B
$12.0B
Research, development and engineering
$3.6B
$3.2B
$3.1B
$2.8B
Marketing and selling
$858.0M
$836.0M
$776.0M
$703.0M
General and administrative
$910.0M
$961.0M
$852.0M
$735.0M
Restructuring charges
$181.0M
—
—
—
Total operating expenses
$5.5B
$5.0B
$4.7B
$4.2B
Income from operations
$8.3B
$7.9B
$7.7B
$7.8B
Interest expense
$269.0M
$247.0M
$238.0M
$228.0M
Interest and other income (expense), net
$1.3B
$532.0M
$300.0M
$39.0M
Income before income taxes
$9.3B
$8.2B
$7.7B
$7.6B
Provision for income taxes
$2.3B
$975.0M
$860.0M
$1.1B
Net income
$7.0B
$7.2B
$6.9B
$6.5B
Basic (in dollars per share)
$8.71
$8.68
$8.16
$7.49
Diluted (in dollars per share)
$8.66
$8.61
$8.11
$7.44
Basic (in shares)
804.0M
827.0M
840.0M
871.0M
Diluted (in shares)
808.0M
834.0M
845.0M
877.0M
Applied Materials, Inc. income statement, quarters
Line item
Jul 26, 2026 · Q3
Apr 26, 2026 · Q2
Jan 25, 2026 · Q1
Jul 27, 2025 · Q3
Revenue
$9.1B
$7.9B
$7.0B
$7.3B
Cost of products sold
$4.5B
$4.0B
$3.6B
$3.7B
Gross profit
$4.6B
$3.9B
$3.4B
$3.6B
Research, development and engineering
$1.1B
$1.0B
$928.0M
$901.0M
Marketing and selling
$249.0M
$233.0M
$222.0M
$224.0M
General and administrative
$162.0M
$164.0M
$189.0M
$204.0M
Legal settlement
$0
$0
$253.0M
—
Restructuring charges
$0
$0
$12.0M
—
Total operating expenses
$1.5B
$1.4B
$1.6B
$1.3B
Income from operations
$3.1B
$2.5B
$1.8B
$2.2B
Interest expense
$68.0M
$69.0M
$69.0M
$66.0M
Interest and other income (expense), net
($100.0M)
$771.0M
$566.0M
$396.0M
Income before income taxes
$2.9B
$3.2B
$2.3B
$2.6B
Provision for income taxes
$369.0M
$419.0M
$302.0M
$784.0M
Net income
$2.5B
$2.8B
$2.0B
$1.8B
Basic (in dollars per share)
$3.20
$3.53
$2.55
$2.23
Diluted (in dollars per share)
$3.17
$3.51
$2.54
$2.22
Basic (in shares)
794.0M
794.0M
793.0M
798.0M
Diluted (in shares)
800.0M
799.0M
799.0M
802.0M
Balance sheet
Applied Materials, Inc. balance sheet, fiscal years
Line item
Oct 26, 2025 · FY
Oct 27, 2024 · FY
Oct 29, 2023 · FY
Oct 30, 2022 · FY
Cash and cash equivalents
$7.2B
$8.0B
$6.1B
$2.0B
Short-term investments
$1.3B
$1.4B
$737.0M
$586.0M
Accounts receivable, net
$5.2B
$5.2B
$5.2B
$6.1B
Inventories
$5.9B
$5.4B
$5.7B
$5.9B
Other current assets
$1.2B
$1.1B
$1.4B
$1.3B
Total current assets
$20.9B
$21.2B
$19.1B
$15.9B
Long-term investments
$4.3B
$2.8B
$2.3B
$2.0B
Property, plant and equipment, net
$4.6B
$3.3B
$2.7B
$2.3B
Goodwill
$3.7B
$3.7B
$3.7B
$3.7B
Purchased technology and other intangible assets, net
$226.0M
$249.0M
$294.0M
$339.0M
Deferred income taxes and other assets
$2.5B
$3.1B
$2.6B
$2.5B
Total assets
$36.3B
$34.4B
$30.7B
$26.7B
Short-term debt
$100.0M
$799.0M
$100.0M
—
Accounts payable and accrued expenses
$5.3B
$4.8B
$4.3B
$4.2B
Contract liabilities
$2.6B
$2.8B
$3.0B
$3.1B
Total current liabilities
$8.0B
$8.5B
$7.4B
$7.4B
Long-term debt
$6.5B
$5.5B
$5.5B
$5.5B
Income taxes payable
$356.0M
$670.0M
$833.0M
$964.0M
Other liabilities
$1.1B
$810.0M
$714.0M
$732.0M
Total liabilities
$15.9B
$15.4B
$14.4B
$14.5B
Preferred stock: $0.01 par value per share; 1 shares authorized; no shares issued
$0.00
$0.00
$0.00
$0.00
Common stock: $0.01 par value per share; 2,500 shares authorized; 793 and 818 shares outstanding at 2025 and 2024, respectively
$8000000.00
$8000000.00
$8000000.00
$8000000.00
Additional paid-in capital
$10.3B
$9.7B
$9.1B
$8.6B
Retained earnings
$55.2B
$49.7B
$43.7B
$37.9B
Treasury stock: 1,241 and 1,211 shares at 2025 and 2024, respectively
-45.0B
-40.1B
-36.3B
—
Accumulated other comprehensive loss
($110.0M)
($168.0M)
($217.0M)
($202.0M)
Total stockholders’ equity
$20.4B
$19.0B
$16.3B
$12.2B
Total liabilities and stockholders’ equity
$36.3B
$34.4B
$30.7B
$26.7B
Applied Materials, Inc. balance sheet, quarters
Line item
Jul 26, 2026
Apr 26, 2026
Jan 25, 2026
Jul 27, 2025
Cash and cash equivalents
$7.0B
$6.3B
$7.2B
$5.4B
Short-term investments
$2.2B
$1.9B
$1.3B
$1.6B
Accounts receivable, net
$7.7B
$6.4B
$5.0B
$5.8B
Inventories
$6.6B
$6.3B
$6.0B
$5.8B
Other current assets
$1.6B
$1.6B
$1.6B
$1.1B
Total current assets
$25.1B
$22.6B
$21.0B
$19.7B
Long-term investments
$5.3B
$5.1B
$5.0B
$4.1B
Property, plant and equipment, net
$5.6B
$5.3B
$4.9B
$4.1B
Goodwill
$3.9B
$3.8B
$3.7B
$3.7B
Purchased technology and other intangible assets, net
$315.0M
$330.0M
$215.0M
$238.0M
Deferred income taxes and other assets
$3.4B
$3.2B
$2.8B
$2.3B
Total assets
$43.5B
$40.3B
$37.6B
$34.2B
Short-term debt
$1.3B
$1.2B
$100.0M
$799.0M
Accounts payable and accrued expenses
$5.8B
$5.2B
$5.2B
$4.6B
Contract liabilities
$3.3B
$2.6B
$2.5B
$2.5B
Total current liabilities
$10.4B
$9.0B
$7.8B
$7.9B
Long-term debt
$5.2B
$5.3B
$6.5B
$5.5B
Income taxes payable
$880.0M
$704.0M
$507.0M
$330.0M
Other liabilities
$1.4B
$1.4B
$1.2B
$1.0B
Total liabilities
$17.9B
$16.4B
$15.9B
$14.7B
Common stock
$8.0M
$8.0M
$8.0M
$8.0M
Additional paid-in capital
$10.6B
$10.5B
$10.3B
$10.1B
Retained earnings
$61.4B
$59.3B
$56.9B
$53.7B
Treasury stock
($46.2B)
($45.8B)
($45.4B)
($44.2B)
Accumulated other comprehensive loss
($165.0M)
($124.0M)
($110.0M)
($102.0M)
Total stockholders’ equity
$25.6B
$23.9B
$21.7B
$19.5B
Total liabilities and stockholders’ equity
$43.5B
$40.3B
$37.6B
$34.2B
Cash flow statement
Applied Materials, Inc. cash flow statement, fiscal years
Line item
Oct 26, 2025 · FY
Oct 27, 2024 · FY
Oct 29, 2023 · FY
Oct 30, 2022 · FY
Net income
$7.0B
$7.2B
$6.9B
$6.5B
Depreciation and amortization
$435.0M
$392.0M
$515.0M
$444.0M
Restructuring charges
$179.0M
$0
$0
($4.0M)
Deferred income taxes
$639.0M
($633.0M)
$24.0M
($223.0M)
(Gain) loss and impairments on investments, net
($792.0M)
—
—
—
Share-based compensation
$668.0M
$577.0M
$490.0M
$413.0M
Other
$31.0M
$47.0M
$40.0M
$36.0M
Accounts receivable
$49.0M
($69.0M)
$903.0M
($1.1B)
Inventories
($494.0M)
$304.0M
$207.0M
($1.6B)
Other current and non-current assets
($119.0M)
$287.0M
($48.0M)
($16.0M)
Accounts payable and accrued expenses
$307.0M
$281.0M
($138.0M)
$390.0M
Contract liabilities
($283.0M)
($126.0M)
($167.0M)
$1.0B
Income taxes payable
$250.0M
$389.0M
($20.0M)
($541.0M)
Other liabilities
$90.0M
$51.0M
$38.0M
$35.0M
Cash provided by operating activities
$8.0B
$8.7B
$8.7B
$5.4B
Capital expenditures
($2.3B)
($1.2B)
($1.1B)
($787.0M)
Cash paid for acquisitions, net of cash acquired
($29.0M)
$0
($25.0M)
($441.0M)
Proceeds from asset sale
$33.0M
—
—
—
Proceeds from sales and maturities of investments
$5.5B
$2.5B
$1.3B
$1.4B
Purchases of investments
($6.1B)
($3.6B)
($1.7B)
($1.5B)
Cash used in investing activities
($2.8B)
($2.3B)
($1.5B)
($1.4B)
Debt borrowings, net of issuance costs
$991.0M
$694.0M
—
$0
Debt repayments
($700.0M)
—
—
$0
Proceeds from commercial paper
$503.0M
$401.0M
$991.0M
—
Repayments of commercial paper
($502.0M)
($400.0M)
($900.0M)
—
Proceeds from common stock issuances
$261.0M
$243.0M
$227.0M
$199.0M
Common stock repurchases
($4.9B)
($3.8B)
($2.2B)
($6.1B)
Tax withholding payments for vested equity awards
($248.0M)
($291.0M)
($179.0M)
($266.0M)
Payments of dividends to stockholders
($1.4B)
($1.2B)
($975.0M)
($873.0M)
Payments of debt issuance costs
($3.0M)
—
—
—
Repayments of principals on finance leases
$0
($102.0M)
($7.0M)
—
Cash used in financing activities
($6.0B)
($4.5B)
($3.0B)
($7.0B)
Increase (decrease) in cash, cash equivalents and restricted cash equivalents
($801.0M)
$1.9B
$4.1B
($3.0B)
Cash, cash equivalents and restricted cash equivalents — beginning of period
$8.1B
$6.2B
$2.1B
$5.1B
Cash, cash equivalents and restricted cash equivalents — end of period
$7.3B
$8.1B
$6.2B
$2.1B
Cash and cash equivalents
$7.2B
$8.0B
$6.1B
$2.0B
Restricted cash equivalents included in deferred income taxes and other assets
$71.0M
$91.0M
$101.0M
$105.0M
Total cash, cash equivalents, and restricted cash equivalents
$7.3B
$8.1B
$6.2B
$2.1B
Cash payments for income taxes
$1.5B
$957.0M
$1.0B
$1.9B
Cash refunds from income taxes
$90.0M
$15.0M
$53.0M
$156.0M
Cash payments for interest
$239.0M
$205.0M
$205.0M
$205.0M
Applied Materials, Inc. cash flow statement, quarters
Line item
Jul 26, 2026 · YTD
Apr 26, 2026 · YTD
Jan 25, 2026 · Q1
Jul 27, 2025 · YTD
Net income
$7.4B
$4.8B
$2.0B
$5.1B
Depreciation and amortization
$413.0M
$262.0M
$127.0M
$321.0M
Restructuring charges
$12.0M
$12.0M
$12.0M
—
(Gain) / loss and impairment on investments
($909.0M)
($1.1B)
($466.0M)
—
Share-based compensation
$545.0M
$376.0M
$207.0M
$512.0M
Deferred income taxes
$25.0M
$74.0M
($78.0M)
$952.0M
Other
($11.0M)
$4.0M
($1.0M)
($298.0M)
Accounts receivable
($2.5B)
($1.2B)
$208.0M
($538.0M)
Inventories
($609.0M)
($401.0M)
($82.0M)
($386.0M)
Other current and non-current assets
($333.0M)
($394.0M)
($154.0M)
($36.0M)
Accounts payable and accrued expenses
$412.0M
($221.0M)
($760.0M)
$135.0M
Contract liabilities
$698.0M
($3.0M)
($94.0M)
($379.0M)
Income taxes payable
$462.0M
$325.0M
$481.0M
($297.0M)
Other liabilities
$1.0M
($9.0M)
$7.0M
$43.0M
Cash provided by operating activities
$5.6B
$2.5B
$1.7B
$5.1B
Capital expenditures
($2.0B)
($1.3B)
($646.0M)
($1.5B)
Cash paid for acquisitions, net of cash acquired
($262.0M)
($175.0M)
$0
($29.0M)
Proceeds from asset sale
$6.0M
$6.0M
—
$33.0M
Proceeds from sales and maturities of investments
$4.6B
$3.2B
$1.1B
$3.9B
Purchases of investments
($5.5B)
($3.5B)
($1.3B)
($5.1B)
Cash used in investing activities
($3.2B)
($1.7B)
($780.0M)
($2.6B)
Proceeds from issuance of commercial paper
$399.0M
$300.0M
$200.0M
$400.0M
Repayments of commercial paper
($400.0M)
($400.0M)
($200.0M)
($400.0M)
Proceeds from common stock issuances
$131.0M
$131.0M
—
$129.0M
Common stock repurchases
($1.2B)
($737.0M)
($337.0M)
($4.0B)
Tax withholding payments for vested equity awards
($437.0M)
($309.0M)
($229.0M)
($210.0M)
Payments of dividends to stockholders
($1.1B)
($730.0M)
($365.0M)
($1.0B)
Payments of debt issuance costs
$0
$0
—
($2.0M)
Cash used in financing activities
($2.6B)
($1.7B)
($931.0M)
($5.1B)
Increase (decrease) in cash, cash equivalents and restricted cash equivalents
($218.0M)
($953.0M)
($25.0M)
($2.7B)
Cash, cash equivalents and restricted cash equivalents — beginning of period
$7.3B
$7.3B
$7.3B
$8.1B
Cash, cash equivalents and restricted cash equivalents — end of period
$7.1B
$6.4B
$7.3B
$5.5B
Cash and cash equivalents
$7.0B
$6.3B
$7.2B
$5.4B
Restricted cash equivalents included in deferred income taxes and other assets
$57.0M
$58.0M
$69.0M
$70.0M
Total cash, cash equivalents and restricted cash equivalents